Improving Heart Failure Readmission Costs and Outcomes With a Hospital-to-Home Readmission Intervention Program

American Journal of Medical Quality : the Official Journal of the American College of Medical Quality
Kenneth BilchickSula Mazimba

Abstract

A retrospective cohort study was performed of the Hospital-to-Home (H2H) program, a rapid clinic follow-up program for patients with recent heart failure (HF) admissions at the University of Virginia Health System. There were 6761 hospitalizations among 4685 patients (age 67.5 ± 14.2 years, 43.9% female), and 759 had H2H follow-up. Thirty day mortality after the initial HF hospitalization was lower in H2H patients (1.84% vs 3.13%; P = .049), and this difference remained significant after adjustment in a multivariable logistic regression model (odds ratio = 0.56 [95% CI = 0.31-099]; P = .046). There also was a 24% reduction in readmission days within the first 30 days after the index admission ( P < .0001), and readmission cost savings were found to be greater than the costs of staffing the H2H clinic. In summary, the H2H program is cost-effective, with significant improvements in survival, readmission days, and readmission costs over 30 days.

Associated Clinical Trials

References

Feb 1, 1974·The American Journal of Cardiology·P K CavesN E Shumway
Jun 3, 1999·Annual Review of Public Health·P DiehrD Y Lin
Feb 21, 2004·Journal of the American College of Cardiology·Damien LogeartAlain Cohen Solal
Nov 23, 2006·The American Journal of Medicine·Mihai GheorghiadeJohn Burnett
Jan 4, 2007·JAMA : the Journal of the American Medical Association·Gregg C FonarowUNKNOWN OPTIMIZE-HF Investigators and Hospitals
Mar 27, 2007·JAMA : the Journal of the American Medical Association·Marvin A KonstamUNKNOWN Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study With Tolvaptan (EVEREST) Investigators
Apr 24, 2007·Heart Failure Reviews·François AllaGerasimos Filippatos
Jul 4, 2007·Health Promotion Practice·Justin G TrogdonDiane Orenstein
Jul 24, 2007·American Heart Journal·Soko SetoguchiSebastian Schneeweiss
Apr 3, 2009·The New England Journal of Medicine·Stephen F JencksEric A Coleman
Mar 4, 2010·European Journal of Heart Failure·Shannon M DunlayJohn A Spertus
May 4, 2010·American Heart Journal·Christopher M O'ConnorUNKNOWN Efficacy of Vasopressin Antagonism in heart Failure Outcome Study with Tolvaptan (EVEREST) investigators
May 6, 2010·JAMA : the Journal of the American Medical Association·Adrian F HernandezLesley H Curtis
Jun 14, 2012·Journal of General Internal Medicine·Hillary D LumSusan E Hardy
Jul 24, 2012·Journal of the American College of Cardiology·Javed Butler, Andreas Kalogeropoulos
Dec 12, 2012·Journal of the American College of Cardiology·Mihai GheorghiadeRobert O Bonow
Jan 24, 2013·JAMA : the Journal of the American Medical Association·Muthiah VaduganathanMihai Gheorghiade
Jul 19, 2013·Circulation. Cardiovascular Quality and Outcomes·Elizabeth H BradleyHarlan M Krumholz
Jul 29, 2015·Joint Commission Journal on Quality and Patient Safety·Paul A HeidenreichBarry M Massie
Dec 18, 2015·Circulation·UNKNOWN Writing Group MembersUNKNOWN Stroke Statistics Subcommittee
Oct 7, 2017·Journal of the American College of Cardiology·Gregg C FonarowClyde W Yancy

❮ Previous
Next ❯

Citations

Oct 15, 2020·The Journal of Clinical Hypertension·Michail GiakoumisUNKNOWN Myocardial Infarction Data Acquisition System (MIDAS 36) Study Group

❮ Previous
Next ❯

Software Mentioned

SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.